Mullen GE - Search Results

1

Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination.

Miura K, Zhou H, Moretz SE, Diouf A, Thera MA, Dolo A, Doumbo O, Malkin E, Diemert D, Miller LH, Mullen GE, Long CA. Miura K, et al. Among authors: mullen ge. J Immunol. 2008 Dec 15;181(12):8776-83. doi: 10.4049/jimmunol.181.12.8776. J Immunol. 2008. PMID: 19050299 Free PMC article. Clinical Trial.

2

The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals.

Crompton PD, Mircetic M, Weiss G, Baughman A, Huang CY, Topham DJ, Treanor JJ, Sanz I, Lee FE, Durbin AP, Miura K, Narum DL, Ellis RD, Malkin E, Mullen GE, Miller LH, Martin LB, Pierce SK. Crompton PD, et al. Among authors: mullen ge. J Immunol. 2009 Mar 1;182(5):3318-26. doi: 10.4049/jimmunol.0803596. J Immunol. 2009. PMID: 19234231 Free PMC article.

3

A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals.

Ellis RD, Mullen GE, Pierce M, Martin LB, Miura K, Fay MP, Long CA, Shaffer D, Saul A, Miller LH, Durbin AP. Ellis RD, et al. Among authors: mullen ge. Vaccine. 2009 Jun 24;27(31):4104-9. doi: 10.1016/j.vaccine.2009.04.077. Epub 2009 May 15. Vaccine. 2009. PMID: 19410624 Free PMC article. Clinical Trial.

4

Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay.

Miura K, Zhou H, Diouf A, Moretz SE, Fay MP, Miller LH, Martin LB, Pierce MA, Ellis RD, Mullen GE, Long CA. Miura K, et al. Among authors: mullen ge. Clin Vaccine Immunol. 2009 Jul;16(7):963-8. doi: 10.1128/CVI.00042-09. Epub 2009 May 13. Clin Vaccine Immunol. 2009. PMID: 19439523 Free PMC article.

5

Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells.

Huaman MC, Mullen GE, Long CA, Mahanty S. Huaman MC, et al. Among authors: mullen ge. Vaccine. 2009 Aug 20;27(38):5239-46. doi: 10.1016/j.vaccine.2009.06.066. Epub 2009 Jul 8. Vaccine. 2009. PMID: 19591795 Free PMC article.

6

Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults.

Pierce MA, Ellis RD, Martin LB, Malkin E, Tierney E, Miura K, Fay MP, Marjason J, Elliott SL, Mullen GED, Rausch K, Zhu D, Long CA, Miller LH. Pierce MA, et al. Vaccine. 2010 Mar 2;28(10):2236-2242. doi: 10.1016/j.vaccine.2009.12.049. Epub 2010 Jan 4. Vaccine. 2010. PMID: 20051276 Free PMC article. Clinical Trial.

7

Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders.

Qian F, Rausch KM, Muratova O, Zhou H, Song G, Diouf A, Lambert L, Narum DL, Wu Y, Saul A, Miller LH, Long CA, Mullen GE. Qian F, et al. Among authors: mullen ge. Vaccine. 2008 May 12;26(20):2521-7. doi: 10.1016/j.vaccine.2008.03.005. Epub 2008 Mar 27. Vaccine. 2008. PMID: 18423804 Free PMC article.

8

Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria.

Mullen GE, Ellis RD, Miura K, Malkin E, Nolan C, Hay M, Fay MP, Saul A, Zhu D, Rausch K, Moretz S, Zhou H, Long CA, Miller LH, Treanor J. Mullen GE, et al. PLoS One. 2008 Aug 13;3(8):e2940. doi: 10.1371/journal.pone.0002940. PLoS One. 2008. PMID: 18698359 Free PMC article. Clinical Trial.

9

Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria.

Malkin EM, Diemert DJ, McArthur JH, Perreault JR, Miles AP, Giersing BK, Mullen GE, Orcutt A, Muratova O, Awkal M, Zhou H, Wang J, Stowers A, Long CA, Mahanty S, Miller LH, Saul A, Durbin AP. Malkin EM, et al. Among authors: mullen ge. Infect Immun. 2005 Jun;73(6):3677-85. doi: 10.1128/IAI.73.6.3677-3685.2005. Infect Immun. 2005. PMID: 15908397 Free PMC article. Clinical Trial.

10

Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians.

Dicko A, Diemert DJ, Sagara I, Sogoba M, Niambele MB, Assadou MH, Guindo O, Kamate B, Baby M, Sissoko M, Malkin EM, Fay MP, Thera MA, Miura K, Dolo A, Diallo DA, Mullen GE, Long CA, Saul A, Doumbo O, Miller LH. Dicko A, et al. Among authors: mullen ge. PLoS One. 2007 Oct 17;2(10):e1045. doi: 10.1371/journal.pone.0001045. PLoS One. 2007. PMID: 17940609 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page